Eli Lilly launches oral weight-loss drug Foundayo in UK
Eli Lilly has launched Foundayo, an oral weight-loss drug, in the UK for weight management and type 2 diabetes. The UK is the first country in Europe where the drug is available.
Intelligence analysis by Qwen 2.5 (3B)
Eli Lilly has launched Foundayo, an oral weight-loss drug, in the UK for weight management and type 2 diabetes. The UK is the first country in Europe where the drug is available.
Eli Lilly made a new medicine called Foundayo that helps people lose weight and fix a sickness called type 2 diabetes. Now people in the UK can get this medicine from their doctor if they want to use it.
Analysis
{"
Foundayo's Availability in the UK":"Eli Lilly has announced the launch of Foundayo in the UK for weight management and type 2 diabetes. The drug, known chemically as orforglipron, will be available via private prescription after the UK’s medicines regulator authorized the drug on August 10. This makes the UK the first country in Europe where the oral treatment is available.","
NICE's Assessment of Foundayo":"The National Institute for Health and Care Excellence (NICE) must assess Foundayo before it can become available on the state-run National Health Service (NHS). NICE has requested further information on Foundayo following its first committee meeting, with no date set for a second review. The agency reiterated that Novo Nordisk’s Wegovy pill has not yet made an evidence submission.","
Pricing and Access":"Foundayo will likely be priced between £100 and £120 ($136 and $164), lower than Lilly’s Mounjaro injection’s £330 price for a month’s supply. Private providers in the UK price the Wegovy weight-loss pill from £74 to £129 per month for initial low doses, with most starting rates tied to multi-month subscription plans. Prices for patients go up as they move to higher doses of the pill. In the U.S., self-pay prices for the Wegovy pill and Foundayo start at $149 per month, and can rise up to $299 and $349 respectively for higher doses."}
Key points
- Eli Lilly launched Foundayo in the UK for weight management and type 2 diabetes
- Foundayo will be available via private prescription in the UK
- NICE must assess Foundayo before it can become available on the NHS
- Foundayo will likely be priced between £100 and £120 ($136 and $164)
- The launch could improve access to effective treatments for weight management and diabetes in the UK
The launch of Foundayo could lead to more people in the UK having access to effective treatments for weight management and diabetes, potentially improving their health outcomes.
However, the availability of Foundayo on the NHS is still uncertain, and some patients may have to pay more for the medicine than they do for other weight-loss treatments.
